Trial NCT02531633

View at ClinicalTrials.gov 
Org. Study IDs: 201677

Last trial update was posted on 2019-07-31

MeSH Interventions

Antibodies, Monoclonal Prednisone

MeSH Conditions

Arteritis Giant Cell Arteritis Polymyalgia Rheumatica

Other Conditions


Stopping Reasons

GSK decision to return rights to sirukumab to Janssen and discontinue sirukumab development in giant cell arteritis.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID